1. 2012
  2. Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses

    Melchers, M., Bontjer, I., Tong, T., Chung, N. P. Y., Klasse, P. J., Eggink, D., Montefiori, D. C., Gentile, M., Cerutti, A., Olson, W. C., Berkhout, B., Binley, J. M., Moore, J. P. & Sanders, R. W., 2012, In: Journal of virology. 86, 5, p. 2488-2500

    Research output: Contribution to journalArticleAcademicpeer-review

  3. V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc

    Berro, R., Klasse, P. J., Jakobsen, M. R., Gorry, P. R., Moore, J. P. & Sanders, R. W., 2012, In: Virology. 427, 2, p. 158-165

    Research output: Contribution to journalArticleAcademicpeer-review

  4. V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc (vol 427, pg 158, 2012)

    Berro, R., Klasse, P. J., Jakobsen, M. R., Gorry, P. R., Moore, J. P. & Sanders, R. W., 2012, In: Virology. 428, 1, p. 76

    Research output: Contribution to journalComment/Letter to the editorAcademic

  5. 2011
  6. A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses

    van Montfort, T., Melchers, M., Isik, G., Menis, S., Huang, P-S., Matthews, K., Michael, E., Berkhout, B., Schief, W. R., Moore, J. P. & Sanders, R. W., 2011, In: Journal of biological chemistry. 286, 25, p. 22250-22261

    Research output: Contribution to journalArticleAcademicpeer-review

  7. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield

    Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P-S., Wang, S-K., Stanfield, R. L., Julien, J-P., Ramos, A., Crispin, M., Depetris, R., Katpally, U., Marozsan, A., Cupo, A., Maloveste, S., Liu, Y., McBride, R., Ito, Y., Sanders, R. W., Ogohara, C. & 11 others, Paulson, J. C., Feizi, T., Scanlan, C. N., Wong, C-H., Moore, J. P., Olson, W. C., Ward, A. B., Poignard, P., Schief, W. R., Burton, D. R. & Wilson, I. A., 2011, In: Science. 334, 6059, p. 1097-1103

    Research output: Contribution to journalArticleAcademicpeer-review

  8. A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells

    Melchers, M., Matthews, K., de Vries, R. P., Eggink, D., van Montfort, T., Bontjer, I., van de Sandt, C., David, K., Berkhout, B., Moore, J. P. & Sanders, R. W., 2011, In: Retrovirology. 8, 1, p. 48

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Clinical evaluation of a soluble trimeric HIV-1 envelope glycoprotein vaccine

    Sanders, R. W., 2011, In: Expert review of vaccines. 10, 8, p. 1117-1120

    Research output: Contribution to journalArticleAcademicpeer-review

  10. HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation

    van Montfort, T., Eggink, D., Boot, M., Tuen, M., Hioe, C. E., Berkhout, B. & Sanders, R. W., 2011, In: Journal of immunology (Baltimore, Md.. 187, 9, p. 4676-4685

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Molecular strategies to design an escape-proof antiviral therapy

    Berkhout, B. & Sanders, R. W., 2011, In: Antiviral research. 92, 1, p. 7-14

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors

    Berro, R., Klasse, P. J., Lascano, D., Flegler, A., Nagashima, K. A., Sanders, R. W., Sakmar, T. P., Hope, T. J. & Moore, J. P., 2011, In: Journal of virology. 85, 16, p. 8227-8240

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 82305